Clinical Trials
523 trialsNCT06856343 2026-05-26
REBECCA
AstraZeneca
Recruiting
NCT06930859 2026-05-22
ELEGANCE
Novartis
Recruiting
NCT05006196 2026-05-20
IMOGEN
Perspectum
Active not recruiting
NCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT07597993 2026-05-20
BEYOND
AstraZeneca
Not yet recruiting
NCT06927648 2026-05-19
CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
AstraZeneca
Recruiting
NCT07347600 2026-05-18
reaINAVO
Hoffmann-La Roche
Recruiting
NCT07593196 2026-05-18
HER2-positive Metastatic Breast Cancer in Kazakhstan
AstraZeneca
Not yet recruiting
NCT05939128 2026-05-15
ERA
AstraZeneca
Active not recruiting
NCT06255041 2026-05-15
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
Completed
NCT07038785 2026-05-15
PINK
SpotitEarly
Recruiting
NCT07070128 2026-05-13
STAR-BREAST
AstraZeneca
Recruiting
NCT07580105 2026-05-12
Clinical Study to Assess the Safety and Performance of Kenko Breast AI+ Medical Device as an Aid to Breast Cancer Diagnosis in Adult Women
Kenko Imalytics S.L.
Not yet recruiting
NCT06830720 2026-05-08
CAROLEEN
Novartis
Recruiting
NCT07527741 2026-05-08
Close2HER
Hoffmann-La Roche
Recruiting
NCT07572162 2026-05-07
Post-market Safety Study of LUMISIGHT
Lumicell, Inc.
Not yet recruiting
NCT06075758 2026-05-06
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
Novartis
Completed
NCT06905301 2026-05-05
IMPULSE
Novartis
Recruiting
NCT07563595 2026-05-04
ELENI
iOMEDICO AG
Not yet recruiting
NCT04981119 2026-04-30
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
NCT05377684 2026-04-30
ROSE
Ipsen
Active not recruiting
NCT06555614 2026-04-28
ADM
DOF Inc.
Recruiting
NCT06555692 2026-04-28
SCderm
DOF Inc.
Active not recruiting
NCT04158258 2026-04-23
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Hoffmann-La Roche
Active not recruiting
NCT06512350 2026-04-22
Identifying Patterns in the Breath of Individuals With Breast Cancer
Breathe BioMedical Inc
Recruiting
NCT05153187 2026-04-21
Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan
Pfizer
Completed
NCT06187103 2026-04-21
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
Active not recruiting
NCT07541703 2026-04-21
Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer
Spotlight Medical
Active not recruiting
NCT02695121 2026-04-17
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
AstraZeneca
Completed
NCT03448926 2026-04-17
PREDICT
PreludeDx
Recruiting
NCT07243002 2026-04-15
REPOWER
Novartis
Recruiting
NCT04767594 2026-04-13
PERFORM
Pfizer
Active not recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT07512063 2026-04-13
A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors
Novartis
Completed
NCT05399329 2026-04-09
Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan
Pfizer
Completed
NCT04916808 2026-04-03
AUS-PREDICT
PreludeDx
Active not recruiting
NCT05478590 2026-04-03
A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting
Pfizer
Completed
NCT06962969 2026-04-02
A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database
Pfizer
Completed
NCT07476170 2026-04-02
Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China
Novartis
Recruiting
NCT04943497 2026-04-01
PROSPERITY
Novartis
Completed
NCT06625333 2026-04-01
PARFENOPA
Novartis
Active not recruiting
NCT07498413 2026-04-01
ROTOR
Novartis
Completed
NCT07505797 2026-04-01
AUDIBLE
iSono Health, Inc.
Recruiting
NCT04654208 2026-03-31
SIRI
Pfizer
Recruiting
NCT06827132 2026-03-23
CASCADE
AstraZeneca
Recruiting
NCT06417801 2026-03-19
Pangeia-2
AstraZeneca
Recruiting
NCT06428799 2026-03-18
EMBLEDDA-MMG
Carebot s.r.o.
Completed
NCT06833853 2026-03-18
CTC-EXPRESS
Menarini Silicon Biosystems, INC
Recruiting
NCT05662345 2026-03-17
ACT-MBC
Menarini Silicon Biosystems, INC
Active not recruiting
NCT05697146 2026-03-16
RosaLEE
Novartis
Active not recruiting